66 related articles for article (PubMed ID: 25038418)
1. Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease.
Feng Y; Liu T; Li XQ; Liu Y; Zhu XY; Jankovic J; Pan TH; Wu YC
Neurosci Lett; 2014 Sep; 579():35-40. PubMed ID: 25038418
[TBL] [Abstract][Full Text] [Related]
2. The neurohormone orexin stimulates hypoxia-inducible factor-1 activity.
Sikder D; Kodadek T
Genes Dev; 2007 Nov; 21(22):2995-3005. PubMed ID: 18006690
[TBL] [Abstract][Full Text] [Related]
3. The role of orexin in Parkinson's disease.
Braun A; Manavis J; Yamanaka A; Ootsuka Y; Blumbergs P; Bobrovskaya L
J Neurosci Res; 2024 Mar; 102(3):e25322. PubMed ID: 38520160
[TBL] [Abstract][Full Text] [Related]
4. The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
Janssen Daalen JM; Koopman WJH; Saris CGJ; Meinders MJ; Thijssen DHJ; Bloem BR
Mov Disord; 2024 Feb; 39(2):273-293. PubMed ID: 38140810
[TBL] [Abstract][Full Text] [Related]
5. Sparing of orexin-A and orexin-B neurons in the hypothalamus and of orexin fibers in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated macaques.
Bensaid M; Tandé D; Fabre V; Michel PP; Hirsch EC; François C
Eur J Neurosci; 2015 Jan; 41(1):129-36. PubMed ID: 25328140
[TBL] [Abstract][Full Text] [Related]
6. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential.
Liu C; Xue Y; Liu MF; Wang Y; Chen L
Neurochem Int; 2020 Sep; 138():104754. PubMed ID: 32422324
[TBL] [Abstract][Full Text] [Related]
7. Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model.
Oliveira LM; Henrique E; Bustelli IB; Netto NFC; Moreira TS; Takakura AC; Caetano AL
Exp Neurol; 2020 Jan; 323():113110. PubMed ID: 31712126
[TBL] [Abstract][Full Text] [Related]
8. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin (Orexin) Replacement Therapies.
Seigneur E; de Lecea L
Med Drug Discov; 2020 Dec; 8():. PubMed ID: 38738170
[TBL] [Abstract][Full Text] [Related]
10. The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration.
Mitroshina EV; Vedunova MV
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731800
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the function and structure impact of deleterious missense SNPs in the human OX1R receptor by computational analysis.
Farajzadeh-Dehkordi M; Mafakher L; Harifi A; Haghdoost-Yazdi H; Piri H; Rahmani B
Sci Rep; 2024 Jan; 14(1):833. PubMed ID: 38191899
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson's disease.
Trabjerg MS; Andersen DC; Huntjens P; Mørk K; Warming N; Kullab UB; Skjønnemand MN; Oklinski MK; Oklinski KE; Bolther L; Kroese LJ; Pritchard CEJ; Huijbers IJ; Corthals A; Søndergaard MT; Kjeldal HB; Pedersen CFM; Nieland JDV
NPJ Parkinsons Dis; 2023 Jan; 9(1):6. PubMed ID: 36681683
[TBL] [Abstract][Full Text] [Related]
13. Orexin-A exerts neuroprotective effect in experimental intracerebral hemorrhage by suppressing autophagy
Zhang D; Cui Y; Zhao M; Zheng X; Li C; Wei J; Wang K; Cui J
Front Cell Neurosci; 2022; 16():1045034. PubMed ID: 36619670
[TBL] [Abstract][Full Text] [Related]
14. Low-intensity focused ultrasound attenuates early traumatic brain injury by OX-A/NF-κB/NLRP3 signaling pathway.
Huang L; Kang J; Chen G; Ye W; Meng X; Du Q; Feng Z
Aging (Albany NY); 2022 Sep; 14(18):7455-7469. PubMed ID: 36126193
[TBL] [Abstract][Full Text] [Related]
15. Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights for Optimizing Patient Outcomes.
Mehra R; Heinzer R; Castillo P
Neurol Ther; 2021 Dec; 10(2):651-672. PubMed ID: 34658002
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Role of Orexinergic Neurons in Parkinson's Disease.
Kumar S; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harassi A; Abdel-Daim MM; Bungau S
Neurotox Res; 2021 Dec; 39(6):2141-2153. PubMed ID: 34495449
[TBL] [Abstract][Full Text] [Related]
17. Orexinergic System in Neurodegenerative Diseases.
Wang Q; Cao F; Wu Y
Front Aging Neurosci; 2021; 13():713201. PubMed ID: 34483883
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia Signaling in Parkinson's Disease: There Is Use in Asking "What HIF?".
Lestón Pinilla L; Ugun-Klusek A; Rutella S; De Girolamo LA
Biology (Basel); 2021 Jul; 10(8):. PubMed ID: 34439955
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease.
Mitroshina EV; Savyuk MO; Ponimaskin E; Vedunova MV
Front Cell Dev Biol; 2021; 9():703084. PubMed ID: 34395432
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
